Home › Recurrent respiratory papillomatosis
Recurrent respiratory papillomatosis clinical trials recruiting in the U.S.
5 studies for Recurrent respiratory papillomatosis are recruiting participants at sites across the United States.
Recently updated studies
Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT07317154Merck IIT: RRP Pembro and Lenvatinib
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT04645602Zopa Retreatment and Vector Shedding in Adults With RRP
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06538480The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Aug 12, 2025 · NCT06412172Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RecruitingObservational study
All ages · All sexes · Updated May 29, 2025 · NCT01793168From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.